Excimer Light Versus Blue Light in Acne

The aim is to assess the efficacy and safety of Excimer Light versus blue light in the treatment of inflammatory acne.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Acne Vulgaris Acneiform Eruptions Sebaceous Gland Diseases Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The use of new light energy in inflammatory acne

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with mild to moderate inflammatory acne lesions

Exclusion criteria

Pregnancy during the first trimester

Female patients with a medical history of PCO
Topical and systemic treatment within the last month and systemic retinoids for 6 months
Patients on systemic steroid treatment or hormonal therapy
Severe systemic illness or malignancy
Photosensitivity
Scarring acne vulgaris

Treatment and study plan

Excimer

Device

Light energy

Primary outcomes

Number of comedones, papules and pustules

Time frame: 2 months

number of lesions

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Excimer Light Versus Blue Light in the Treatment of Inflammatory Acne, a Split Face Randomized Controlled Trial.

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Dec 10, 2024
Registry last updated: May 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting